Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Wakunaga prepares novel antibacterial agents

May 9, 1997

Antiparasitic depsipeptides from Meiji Seika

May 9, 1997

AMBI to submit IND for nisin

May 8, 1997

FDA requests additional data to support Gilead's NDA for HSV treatment

May 8, 1997

MedImmune reports further clinical results for MEDI-493

May 8, 1997

Pharmacia & Upjohn prepares new antibacterial agents

May 8, 1997

N-Oxide oxazolidinones from Pharmacia & Upjohn

May 7, 1997

Salix to commence clinical trials with Normix

May 6, 1997

Gilead's cidofovir injection approved in the European Union

May 6, 1997

New ganciclovir derivative from Norsk Hydro for HSV infections

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...